Skip to main content
. Author manuscript; available in PMC: 2013 Jul 22.
Published in final edited form as: Circ Res. 2012 Apr 27;110(9):1226–1237. doi: 10.1161/CIRCRESAHA.111.246868

Table.

Age-Associated Changes in the Heart

  1. Functional changes

    • Cardiac changes

      • Diastolic dysfunction (decreased left ventricular diastolic compliance, impaired relaxation, reduced early diastolic filling, increased late diastolic filling)

      • Increased left ventricular wall thickness

      • Impaired left ventricular ejection and heart rate reserve capacity

      • Altered heart rhythm (decreased heart rate variability, increased cardiac arrhythmias)

      • Deficits in sympathetic modulation of heart rate and left ventricular contractility

      • Prolongation of cardiac action potential

    • Vascular changes

      • Increased arterial stiffness

      • Increased systolic arterial pressure, increased pulse pressure

    • Endothelial dysfunction

  2. Histological and cellular changes

    • Decrease in total number of cardiomyocytes (increased apoptosis and necrosis)

    • Increased myocyte size (myocyte hypertrophy)

    • Increased collagen content in the connective tissue of the heart

    • Increased cardiac fibrosis

    • Decreased No. of pacemaker cells

    • Prolongation of cardiac action potential

    • Reduced regenerative capacity and decline in number of cardiac stem cells

    • Aortic wall thickness and arterial intimal thickening

  3. Molecular changes

    • Blunted cardiac β-adrenergic response

      • Decreased cardiac β receptors, decreased G-protein signaling

    • Impaired calcium handling

      • Impaired calcium pumping by SERCA2

      • Reduced expression and activity of SERCA2

    • Impaired mitochondrial function

      • Accumulated mutations and deletions within mitochondrial DNA

      • Increased accumulation of oxidative damage

      • Mitochondrial loss

    • Alterations in cardiac metabolism

      • Decrease in myocardial fat utilization and oxidation

      • TCA compromised, increased glycolysis

      • Renin-angiotensin-aldosterone system activation

      • Increased cardiac angiotensin II concentrations

      • Reduced insulin/IGF signaling